TM4SF1 expression profiles in HR+HER2- breast cancer tissues were tested by immunohistochemistry and qRT-PCR assay; its roles in HR+HER2- breast cancer development were investigated upon TM4SF1 overexpression or knockdown. Here, ERBB2 is linked to breast carcinoma.